{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T10:27:55Z","timestamp":1744799275994,"version":"3.38.0"},"reference-count":117,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.nephro.2020.09.003","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T19:30:50Z","timestamp":1610479850000},"page":"18-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Atteintes cardiovasculaires associ\u00e9es \u00e0 la polykystose r\u00e9nale autosomique dominante"],"prefix":"10.1684","volume":"17","author":[{"given":"Mouad","family":"Hamzaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaspard","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9my","family":"Bellien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Guerrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2020.09.003_bib0590","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2020.09.003_bib0595","first-page":"1356","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2020.09.003_bib0600","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 4","key":"10.1016\/j.nephro.2020.09.003_bib0605","doi-asserted-by":"crossref","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival \u2013 an analysis of data from the ERA-EDTA registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2020.09.003_bib0610","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCULATIONAHA.107.710111","article-title":"Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1","volume":"117","author":"Nauli","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2020.09.003_bib0615","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/labinvest.2010.159","article-title":"Pkd1-inactivation in vascular smooth muscle cells and adaptation to hypertension","volume":"91","author":"Hassane","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.nephro.2020.09.003_bib0620","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2009.08.045","article-title":"Polycystin-1\u00a0and -2\u00a0dosage regulates pressure sensing","volume":"139","author":"Sharif-Naeini","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.nephro.2020.09.003_bib0625","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.118.034731","article-title":"Polycystin-1\u00a0assembles with Kv channels to govern cardiomyocyte repolarization and contractility","volume":"140","author":"Altamirano","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2020.09.003_bib0630","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/sdi.12696","article-title":"Clinical problems in hemodialysis patients with autosomal dominant polycystic kidney disease","volume":"31","author":"Kocyigit","year":"2018","journal-title":"Semin Dial"},{"issue":"11\u00a0Pt 1","key":"10.1016\/j.nephro.2020.09.003_bib0635","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.amjhyper.2004.06.020","article-title":"Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population","volume":"17","author":"Kelleher","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.nephro.2020.09.003_bib0640","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2020.09.003_bib0645","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrneph.2017.127","article-title":"New treatment paradigms for ADPKD: moving towards precision medicine","volume":"13","author":"Lanktree","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0650","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic kidney disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib0655","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.nephro.2020.09.003_bib0660","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.2018.15870","article-title":"Effect of lanreotide on kidney function in patients with autosomal dominant polycystic kidney disease","volume":"320","author":"Meijer","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2020.09.003_bib0665","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s10157-019-01748-z","article-title":"Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease","volume":"23","author":"Kocyigit","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0670","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2215\/CJN.02810608","article-title":"Prospective change in renal volume and function in children with ADPKD","volume":"4","author":"Cadnapaphornchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0675","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1681\/ASN.V491654","article-title":"The spectrum of autosomal dominant polycystic kidney disease in children","volume":"4","author":"Fick","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0680","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/archdischild-2015-310221","article-title":"Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis","volume":"101","author":"Marlais","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nephro.2020.09.003_bib0685","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00126097-200306000-00003","article-title":"Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease","volume":"8","author":"Seeman","year":"2003","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.nephro.2020.09.003_bib0690","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2215\/CJN.11401017","article-title":"Prevalence of hypertension in children with early-stage ADPKD","volume":"13","author":"Massella","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0695","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000166929","article-title":"Hypertension of polycystic kidney disease: mechanisms and hemodynamic alterations","volume":"5","author":"Valvo","year":"1985","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0700","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1291\/hypres.27.221","article-title":"Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease","volume":"27","author":"Ramunni","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.nephro.2020.09.003_bib0705","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ki.1992.28","article-title":"Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease","volume":"41","author":"Watson","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib0710","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ki.1994.374","article-title":"Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members","volume":"46","author":"Barrett","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib0715","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ki.1988.233","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"34","author":"Bell","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib0720","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ki.1991.238","article-title":"Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease","volume":"40","author":"Harrap","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib0725","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000354317","article-title":"A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease","volume":"38","author":"Kocyigit","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0730","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12882-015-0075-8","article-title":"Increased urinary Angiotensinogen\/Creatinine (AGT\/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients","volume":"16","author":"Park","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0735","doi-asserted-by":"crossref","first-page":"F874","DOI":"10.1152\/ajprenal.00209.2017","article-title":"Urinary renin-angiotensin markers in polycystic kidney disease","volume":"313","author":"Salih","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0740","doi-asserted-by":"crossref","unstructured":"MacKay CE, Leo MD, Fern\u00e1ndez-Pe\u00f1a C, Hasan R, Yin W, Mata-Daboin A, et al. Intravascular flow stimulates PKD2 (polycystin-2) channels in endothelial cells to reduce blood pressure. Elife. 2020 May 4;9:e56655. doi: 10.7554\/eLife.56655. PMID: 32364494; PMCID: PMC7228764.","DOI":"10.7554\/eLife.56655"},{"key":"10.1016\/j.nephro.2020.09.003_bib0745","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nephro.2020.09.003_bib0750","doi-asserted-by":"crossref","first-page":"433","DOI":"10.33549\/physiolres.930324","article-title":"Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease","volume":"52","author":"Merta","year":"2003","journal-title":"Physiol Res"},{"key":"10.1016\/j.nephro.2020.09.003_bib0755","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1159\/000068518","article-title":"Expression and cellular localisation of renal endothelin-1\u00a0and endothelin receptor subtypes in autosomal-dominant polycystic kidney disease","volume":"93","author":"Ong","year":"2003","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0760","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40620-018-0514-2","article-title":"The association of endothelin-1\u00a0levels with renal survival in polycystic kidney disease patients","volume":"32","author":"Kocyigit","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0770","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.V12112427","article-title":"Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension","volume":"12","author":"Klein","year":"2001","journal-title":"JASN"},{"key":"10.1016\/j.nephro.2020.09.003_bib0775","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40620-018-0496-0","article-title":"Effects of fenoldopam on renal blood flow in hypertensive chronic kidney disease","volume":"32","author":"Rovella","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0765","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000013382","article-title":"Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives","volume":"18","author":"Cerasola","year":"1998","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0780","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/ndt\/14.5.1113","article-title":"Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease","volume":"14","author":"Ecder","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2020.09.003_bib0785","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/01.ASN.0000018407.60002.B9","article-title":"Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study","volume":"13","author":"Schrier","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0790","doi-asserted-by":"crossref","first-page":"c18","DOI":"10.1159\/000081790","article-title":"Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease","volume":"99","author":"Nutahara","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2020.09.003_bib0795","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ndt\/gfm731","article-title":"Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease","volume":"23","author":"Zeltner","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2020.09.003_bib0800","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2020.09.003_bib0805","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","author":"Torres","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2020.09.003_bib0810","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.10.018","article-title":"Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease","volume":"91","author":"Torres","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib0815","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.kint.2020.04.053","article-title":"Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease","volume":"98","author":"Kramers","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib0820","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2020.09.003_bib0825","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"JASN"},{"key":"10.1016\/j.nephro.2020.09.003_bib0830","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2215\/CJN.04610511","article-title":"Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease","volume":"6","author":"Perrone","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0835","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ekir.2017.05.014","article-title":"Autosomal dominant polycystic kidney patients may be predisposed to various cardiomyopathies","volume":"2","author":"Chebib","year":"2017","journal-title":"Kidney Int Reports"},{"issue":"2","key":"10.1016\/j.nephro.2020.09.003_bib0840","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1021\/bi0267792","article-title":"Polycystin-2\u00a0interacts with troponin I, an angiogenesis inhibitor","volume":"42","author":"Li","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.nephro.2020.09.003_bib0845","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0022-2836(02)01333-5","article-title":"Polycystin-2\u00a0associates with tropomyosin-1, an actin microfilament component","volume":"325","author":"Li","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0850","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.114.013537","article-title":"Polycystin-1\u00a0is a cardiomyocyte mechanosensor that governs L-Type Ca2+ channel protein stability","volume":"131","author":"Pedrozo","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2020.09.003_bib0855","doi-asserted-by":"crossref","first-page":"e2623","DOI":"10.1097\/MD.0000000000002623","article-title":"New-onset atrial fibrillation is associated with polycystic kidney disease: a nationwide population-based Cohort Study","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nephro.2020.09.003_bib0860","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000025693","article-title":"Contractility and endothelium-dependent relaxation of resistance vessels in polycystic kidney disease rats","volume":"36","author":"Wang","year":"1999","journal-title":"J Vasc Res"},{"key":"10.1016\/j.nephro.2020.09.003_bib0865","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.V1181371","article-title":"Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease","volume":"11","author":"Wang","year":"2000","journal-title":"JASN"},{"key":"10.1016\/j.nephro.2020.09.003_bib0870","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib0875","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/ndt\/gfg351","article-title":"Autosomal dominant polycystic kidney disease: modifier genes and endothelial dysfunction","volume":"18","author":"Devuyst","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2020.09.003_bib0880","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/j.ajkd.2004.01.011","article-title":"Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease","volume":"43","author":"Kocaman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2020.09.003_bib0885","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40620-014-0045-4","article-title":"Pentraxin 3\u00a0as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease","volume":"27","author":"Kocyigit","year":"2014","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0890","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2014.241","article-title":"Polycystin deficiency induces dopamine-reversible alterations in flow-mediated dilatation and vascular nitric oxide release in humans","volume":"87","author":"Lorthioir","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib0895","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000353730","article-title":"Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease","volume":"123","author":"Kocyigit","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2020.09.003_bib0900","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000094402","article-title":"Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease","volume":"26","author":"Clausen","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0905","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/ndt\/gfp136","article-title":"Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function","volume":"24","author":"Azurmendi","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2020.09.003_bib0910","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ndt\/gfw013","article-title":"Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease","volume":"32","author":"Nowak","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2020.09.003_bib0915","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2215\/CJN.02330607","article-title":"Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries","volume":"3","author":"Turkmen","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0920","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/SMJ.0b013e3181d80cae","article-title":"Improvement of coronary flow velocity reserve with telmisartan in patients with autosomal-dominant polycystic kidney disease","volume":"103","author":"Alisir","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.nephro.2020.09.003_bib0925","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1445-5994.2010.02404.x","article-title":"Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease","volume":"42","author":"Turkmen","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.nephro.2020.09.003_bib0930","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2215\/CJN.05850518","article-title":"Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease","volume":"13","author":"Nowak","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0935","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/HYPERTENSIONAHA.111.172080","article-title":"Dopamine receptor type 5\u00a0in the primary cilia has dual chemo- and mechano-sensory roles","volume":"58","author":"Abdul-Majeed","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.nephro.2020.09.003_bib0940","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5551\/jat.37895","article-title":"Associations of cardiovascular risk factors with carotid intima-media thickness in middle-age adults and elders","volume":"24","author":"Wu","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.nephro.2020.09.003_bib0945","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/ATVBAHA.113.301844","article-title":"Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study","volume":"33","author":"Baldassarre","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0950","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/ATVBAHA.108.173609","article-title":"Correlation between carotid intimal\/medial thickness and atherosclerosis: a point of view from pathology","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0955","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1440-1797.2008.01049.x","article-title":"Carotid vascular remodelling in patients with autosomal dominant polycystic kidney disease","volume":"14","author":"Rong","year":"2009","journal-title":"Nephrology"},{"key":"10.1016\/j.nephro.2020.09.003_bib0960","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ndt\/gfw013","article-title":"Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease","volume":"32","author":"Nowak","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2020.09.003_bib0965","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00467-018-3964-9","article-title":"Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study","volume":"33","author":"Karava","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0970","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/HYPERTENSIONAHA.108.115972","article-title":"Carotid plaque, arterial stiffness gradient, and remodeling in hypertension","volume":"52","author":"Beaussier","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.nephro.2020.09.003_bib0975","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.ajkd.2018.04.005","article-title":"Arterial stiffness in CKD: a review","volume":"73","author":"Townsend","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2020.09.003_bib0980","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrcardio.2017.155","article-title":"Arterial stiffness as a risk factor for clinical hypertension","volume":"15","author":"Safar","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0985","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0990","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jacc.2015.08.888","article-title":"Carotid stiffness is associated with incident stroke: a systematic review and individual participant data meta-analysis","volume":"66","author":"van Sloten","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nephro.2020.09.003_bib0995","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","article-title":"Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients","volume":"37","author":"Laurent","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.nephro.2020.09.003_bib1000","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1532-5415.2010.02905.x","article-title":"Spironolactone and hydocholorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension","volume":"58","author":"Kithas","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nephro.2020.09.003_bib1005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000339440","article-title":"Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients","volume":"36","author":"Kocyigit","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib1010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2310\/JIM.0b013e31828218e7","article-title":"Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease","volume":"61","author":"Orscelik","year":"2013","journal-title":"J Investig Med"},{"key":"10.1016\/j.nephro.2020.09.003_bib1015","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2215\/CJN.05850518","article-title":"Vascular dysfunction, oxidative stress, and inflammation in autosomal dominant polycystic kidney disease","volume":"13","author":"Nowak","year":"2018","journal-title":"CJASN"},{"key":"10.1016\/j.nephro.2020.09.003_bib1020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1556\/2060.105.2018.2.17","article-title":"Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney disease","volume":"105","author":"S\u00e1gi","year":"2018","journal-title":"Physiol Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib1025","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s11255-015-1022-0","article-title":"Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function","volume":"47","author":"Gul","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib1030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/0886022X.2016.1144209","article-title":"Autosomal dominant polycystic kidney disease and coronary artery dissection or aneurysm: a systematic review","volume":"38","author":"Neves","year":"2016","journal-title":"Renal Failure"},{"key":"10.1016\/j.nephro.2020.09.003_bib1035","doi-asserted-by":"crossref","unstructured":"S. Lefevre, MP. Audr\u00e9zet, JM. Halimi, C. Vigneau, M. Hourmant, J. Dantal, et al., Prevalence of detected intracranial aneurysms in autosomal dominant polycystic kidney disease (adpkd) in 2796 patients from the genkyst cohort, Nephrology Dialysis Transplantation, 2019, 34; gfz101.SaO006, https:\/\/doi.org\/10.1093\/ndt\/gfz101.SaO006.","DOI":"10.1093\/ndt\/gfz101.SaO006"},{"issue":"Suppl 1","key":"10.1016\/j.nephro.2020.09.003_bib1040","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.nephro.2017.01.018","article-title":"Screening and management of intracranial aneurisms in patients with autosomal dominant polycystic kidney disease","volume":"13","author":"Flahault","year":"2017","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2020.09.003_bib1045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.kint.2017.08.016","article-title":"Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective","volume":"93","author":"Flahault","year":"2018","journal-title":"Kidney International"},{"key":"10.1016\/j.nephro.2020.09.003_bib1050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/STROKEAHA.110.578740","article-title":"Screening for intracranial aneurysm in 355\u00a0patients with autosomal-dominant polycystic kidney disease","volume":"42","author":"Xu","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.nephro.2020.09.003_bib1055","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2215\/CJN.14691218","article-title":"Presymptomatic screening for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease","volume":"14","author":"Sanchis","year":"2019","journal-title":"CJASN"},{"key":"10.1016\/j.nephro.2020.09.003_bib1060","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2215\/CJN.09731110","article-title":"Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease","volume":"6","author":"Irazabal","year":"2011","journal-title":"CJASN"},{"key":"10.1016\/j.nephro.2020.09.003_bib1065","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(03)13773-7","article-title":"Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype","volume":"361","author":"Rossetti","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2020.09.003_bib1070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2020.09.003_bib1075","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2215\/CJN.02100219","article-title":"Screening for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease","volume":"14","author":"Flahault","year":"2019","journal-title":"CJASN"},{"key":"10.1016\/j.nephro.2020.09.003_bib1080","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1148\/radiol.2019181399","article-title":"MR angiography screening and surveillance for intracranial aneurysms in autosomal dominant polycystic kidney disease: a cost-effectiveness analysis","volume":"291","author":"Malhotra","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.nephro.2020.09.003_bib1085","doi-asserted-by":"crossref","first-page":"30013","DOI":"10.1038\/srep30013","article-title":"Identification of MMP1\u00a0as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models","volume":"6","author":"Ameku","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nephro.2020.09.003_bib1090","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrneph.2015.128","article-title":"Vascular complications in autosomal dominant polycystic kidney disease","volume":"11","author":"Perrone","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib1095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jama.283.7.897","article-title":"The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease","volume":"283","author":"Hagan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2020.09.003_bib1100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/nep.12373","article-title":"Aortic dissection in patients with autosomal dominant polycystic kidney disease: a series of two cases and a review of the literature","volume":"20","author":"Silverio","year":"2015","journal-title":"Nephrology"},{"key":"10.1016\/j.nephro.2020.09.003_bib1105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjcard.2018.10.012","article-title":"Conditions and factors associated with spontaneous coronary artery dissection (from a national population-based cohort study)","volume":"123","author":"Krittanawong","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nephro.2020.09.003_bib1110","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.028","article-title":"Vertebral artery dissection in patients with autosomal dominant polycystic kidney disease","volume":"23","author":"Kuroki","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.nephro.2020.09.003_bib1115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.amjcard.2018.10.030","article-title":"Risk of ascending aortic aneurysm in patients with autosomal dominant polycystic kidney disease","volume":"123","author":"Bouleti","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nephro.2020.09.003_bib1120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000343281","article-title":"Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Helal","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib1125","first-page":"211","article-title":"Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease","volume":"56","author":"Bardaj\u00ed","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib1130","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/ajkd.2001.29216","article-title":"Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1","volume":"38","author":"Lumiaho","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2020.09.003_bib1135","doi-asserted-by":"crossref","first-page":"eaax0290","DOI":"10.1126\/scitranslmed.aax0290","article-title":"Primary cilia defects causing mitral valve prolapse","volume":"11","author":"Toomer","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.nephro.2020.09.003_bib1140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/j.ajkd.2019.05.023","article-title":"An implanted blood vessel support device for arteriovenous fistulas: a randomized controlled trial","volume":"75","author":"Karydis","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2020.09.003_bib1145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000355548","article-title":"Arteriovenous fistula aneurysm in patients on regular hemodialysis: prevalence and risk factors","volume":"124","author":"Jankovic","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2020.09.003_bib1150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000045629","article-title":"Dimensions of arteriovenous fistulas in patients with autosomal dominant polycystic kidney disease","volume":"85","author":"Hadimeri","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2020.09.003_bib1155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5414\/CNP61344","article-title":"Vascular abnormalities in patients with autosomal dominant polycystic kidney disease \u2013 the influence on arteriovenous fistula creation","volume":"61","author":"Weyde","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2020.09.003_bib1160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/j.ajkd.2004.04.026","article-title":"Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state","volume":"44","author":"Martinez-Vea","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2020.09.003_bib1165","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/08037051.2012.680691","article-title":"Impairment of heart rate recovery index in autosomal-dominant polycystic kidney disease patients without hypertension","volume":"21","author":"Orscelik","year":"2012","journal-title":"Blood Press"},{"key":"10.1016\/j.nephro.2020.09.003_bib0585","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2014.03.014","article-title":"Exercise capacity in polycystic kidney disease","volume":"64","author":"Reinecke","year":"2014","journal-title":"Am J Kidney Dis"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725520303606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725520303606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2020.09.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:11:06Z","timestamp":1741191066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725520303606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1769725520303606"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2020.09.003","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atteintes cardiovasculaires associ\u00e9es \u00e0 la polykystose r\u00e9nale autosomique dominante","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}